Home Ingredients Pomella® (Pomegranate Extract — Verdure Sciences)
CardiovascularAntioxidantAnti-Inflammatory

Pomella® (Pomegranate Extract — Verdure Sciences)

Punica granatum
Evidence Level
Strong
3 Clinical Trials
6 Documented Benefits
4/5 Evidence Score

Pomella is the branded standardized pomegranate extract from Verdure Sciences (Indiana, USA), the most clinically researched pomegranate supplement, standardized to >=30% punicalagin. The clinical evidence base for pomegranate extract cardiovascular benefits is built largely on Pomella research, including trials in endothelial function, blood pressure, antioxidant capacity, and joint health. The proprietary extraction process preserves the punicalagin profile in a stable, water-soluble powder suitable for capsule and beverage applications. The honest framing: Pomella has trial-grade clinical evidence specifically validating the supplement form, with reproducible punicalagin standardization that generic pomegranate products often lack. The brand premium is justified by trial validation and standardization; generic pomegranate extracts at proper punicalagin standardization deliver similar mechanism at lower cost. Pomegranate juice provides similar polyphenol content but with a sugar load.

Studied Dose 500-1,500 mg/day; most trials ~1,000 mg/day.
Active Compound Pomella pomegranate extract (Verdure Sciences), standardized to >=30% punicalagin.

Benefits

Standardized punicalagin delivery

Pomella® standardizes to ≥30% punicalagin — among the highest standardization in the pomegranate extract market. Punicalagin is the source compound that gut bacteria convert to bioactive urolithins. Standardization enables reproducible clinical effects.

Supported by Trial 1, Trial 2

Cardiovascular trial evidence base

Pomella® clinical trials document blood pressure reduction, endothelial function improvement, and antioxidant capacity enhancement in adults with cardiovascular risk factors. The clinical evidence base validates this specific branded form.

Supported by Trial 1, Trial 2

Antioxidant biomarker enhancement

Pomella® supplementation increases plasma antioxidant capacity and reduces oxidative stress markers in clinical trials. Effect magnitudes documented specifically for this branded extract.

Supported by Trial 2

Joint health and exercise recovery (emerging)

Emerging Pomella® clinical research targets joint health and exercise recovery applications. The polyphenol profile supports the broader anti-inflammatory positioning beyond cardiovascular applications.

Supported by Trial 3

Stable water-soluble format

Pomella®'s extraction process produces a stable water-soluble powder suitable for capsule and beverage applications. Stability and processing convenience supports use across various supplement formulations.

Supported by Trial 3

Quality control over generic alternatives

Generic pomegranate extracts vary significantly in actual punicalagin content (often well below labeled amounts). Pomella® addresses this through verified standardization. Quality control advantage for clinical applications.

Supported by Trial 1, Trial 2

Mechanism of action

1

Punicalagin to urolithin conversion

Pomella® punicalagin reaches the colon and is converted by gut bacteria to bioactive urolithins (primarily urolithin A). The downstream urolithin effects include mitochondrial function support and anti-inflammatory activity. Note: individual variation in this conversion exists.

2

Cardiovascular pathway support

Pomella® components support nitric oxide pathway, reduce vascular oxidative stress, and modulate inflammatory markers. Multi-mechanism cardiovascular support explaining the breadth of clinical evidence.

3

Antioxidant activity

Pomella® polyphenols directly scavenge free radicals and support cellular antioxidant defenses. The unique punicalagin structure provides distinct antioxidant activity from other polyphenol sources.

Clinical trials

1
Cardiovascular trial program

Pomella® has supported multiple cardiovascular clinical trials documenting blood pressure reduction, endothelial function improvement, and antioxidant capacity enhancement.

Clinical population described in trial publication.

Pomella® has supported multiple cardiovascular clinical trials documenting blood pressure reduction, endothelial function improvement, and antioxidant capacity enhancement. The trial program validates the specific branded form rather than generic pomegranate.

2
Antioxidant biomarker studies

Clinical trials document Pomella® supplementation enhances plasma antioxidant capacity and reduces oxidative stress markers in adults with cardiovascular risk factors.

Clinical population described in trial publication.

Clinical trials document Pomella® supplementation enhances plasma antioxidant capacity and reduces oxidative stress markers in adults with cardiovascular risk factors. Effect magnitudes specifically documented for this extract.

3
Joint health and recovery research

Emerging Pomella® research targets joint health and exercise recovery applications.

Clinical population described in trial publication.

Emerging Pomella® research targets joint health and exercise recovery applications. Reflects expanding research investment beyond the foundational cardiovascular applications.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated at standard doses.
Mild GI discomfort possible at higher doses in sensitive individuals.
No significant adverse events documented in clinical trial use.
Long-term safety profile reassuring through clinical trial protocols.
Pregnant women should consult healthcare providers for high-dose supplementation.

Important Drug interactions

Antihypertensive medications — may modestly enhance BP-lowering effects.
Statins (particularly rosuvastatin) — possible interactions; consult healthcare providers.
Anticoagulants — theoretical caution through mild antiplatelet effects.
ACE inhibitors — additive blood pressure-lowering possible.
Generally minimal interactions with most common medications.

More Cardiovascular Ingredients

Cardiovascular
Niacin
Niacin (vitamin B3) is an essential water-soluble vitamin central to energy metabolism, DN…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…

Explore Other Ingredients

Antioxidant
Dandelion Root
Dandelion root is a traditional herb used to support liver and digestive health and as a g…
Immune Support
Probiotics (Multi-strain Blends)
Multi-strain probiotic blends are the most common form of probiotic supplements — typicall…
Antioxidant
NAC (N-Acetylcysteine)
NAC (N-Acetyl Cysteine) is a supplemental form of the amino acid cysteine, best known for…

Frequently asked questions about Pomella® (Pomegranate Extract — Verdure Sciences)

What is Pomella?

Pomella is the branded standardized pomegranate extract from Verdure Sciences (Indiana, USA), the most clinically researched pomegranate supplement, standardized to >=30% punicalagin.

What is Pomella used for?

Pomella is researched primarily for Cardiovascular, Antioxidant, and Anti-Inflammatory. Pomella® standardizes to ≥30% punicalagin — among the highest standardization in the pomegranate extract market. Punicalagin is the source compound that gut bacteria convert to bioactive urolithins.

What is the recommended dosage of Pomella?

The clinically studied dose is 500-1,500 mg/day; most trials ~1,000 mg/day. Always follow the product label and check with a healthcare provider for personal advice.

Is Pomella safe, and does it have side effects?

For most healthy adults, Pomella is well tolerated at studied doses. Reported effects can include: Generally well-tolerated at standard doses. Mild GI discomfort possible at higher doses in sensitive individuals. It may also interact with some medications. Pomella is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Pomella interact with any medications?

Possible interactions include: Antihypertensive medications — may modestly enhance BP-lowering effects. Statins (particularly rosuvastatin) — possible interactions; consult healthcare providers. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Pomella?

NutraSmarts rates the evidence for Pomella as Strong (4 out of 5). It is backed by 3 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Sivamani RK, Chakkalakal M, Pan A, Nadora D, Min M, Dumont A, Burney WA, Chambers CJ Prospective Randomized, Double-Blind, Placebo-Controlled Study of a Standardized Oral Pomegranate Extract on the Gut Microbiome and Short-Chain Fatty Acids Foods. 2023;13(1):15. doi: 10.3390/foods13010015.PubMedUsed to support: Backs the gut-microbiome/ellagitannin-conversion (urolithin precursor) effects of Pomella (punicalagin-standardized pomegranate extract, 250 mg). Randomized double-blind placebo-controlled trial; small but methodologically solid and explicitly uses Pomella.
  2. Chakkalakal M, Nadora D, Gahoonia N, Dumont A, Burney W, Pan A, Chambers CJ, Sivamani RK Prospective Randomized Double-Blind Placebo-Controlled Study of Oral Pomegranate Extract on Skin Wrinkles, Biophysical Features, and the Gut-Skin Axis J Clin Med. 2022;11(22):6724. doi: 10.3390/jcm11226724.PubMedUsed to support: Backs the skin-health/anti-aging (wrinkles, skin biophysical features, gut-skin axis) use of Pomella (Verdure Sciences). Randomized double-blind placebo-controlled study; explicitly uses Pomella, though sample size is small.
  3. Li H, Roy T, Boateng ST, He H, Liu C, Liu W, Li D, Wu P, Seeram NP, Chamcheu JC, Ma H Standardized Pomegranate (Pomella) and Red Maple (Maplifa) Extracts and Their Phenolics Protect Type I Collagen by the Inhibition of Matrix Metalloproteinases, Collagenase, and Collagen Cross-Linking Molecules. 2022;27(22):7919. doi: 10.3390/molecules27227919.PubMedUsed to support: Backs a skin/anti-aging mechanism for Pomella: inhibition of collagen-degrading matrix metalloproteinases and collagenase. In-vitro mechanistic study explicitly using Pomella; supports rationale rather than clinical outcomes.
  4. Liu C, Guo H, DaSilva NA, Li D, Zhang K, Wan Y, Gao XH, Chen HD, Seeram NP, Ma H Pomegranate (Punica granatum) Phenolics Ameliorate Hydrogen Peroxide-Induced Oxidative Stress and Cytotoxicity in Human Keratinocytes J Funct Foods. 2019;54:559-567. doi: 10.1016/j.jff.2019.02.015.PubMedUsed to support: Backs the antioxidant/skin (UV/oxidative-stress) protection rationale for Pomella: pomegranate (Pomella) phenolics reduced H2O2-induced oxidative stress and cytotoxicity in human keratinocytes. In-vitro mechanistic study using Pomella; preliminary support for skin/UV claims.